Efficacy and safety of certolizumab pegol for Crohn's disease in clinical practice

E-ISSN： 1365-2036|42|4|428-440

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.42, Iss.4, 2015-08, pp. : 428-440

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Population pharmacokinetic analysis of certolizumab pegol in patients with Crohn's disease

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 8, 2015-08 ,pp. : 866-874

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: effectiveness of split‐dose certolizumab pegol for Crohn's disease

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 38, Iss. 11-12, 2013-12 ,pp. : 1412-1412

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical and demographic characteristics predictive of treatment outcomes for certolizumab pegol in moderate to severe Crohn's disease: analyses from the 7‐year PRECiSE 3 study

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 3, 2015-08 ,pp. : 330-342

John Wiley & Sons Inc

Access to resources Recommend Favorite

Certolizumab pegol for the treatment of rheumatoid arthritis

By Modesto I Spinello M Nicchi F Cottone M

Therapy, Vol. 8, Iss. 4, 2011-07 ,pp. : 391-402

Future Medicine

Access to resources Recommend Favorite

Safety and Efficacy of Antimicrobial Mouthrinses in Clinical Practice

By DePaola Louis G. Spolarich Ann Eshenaur

Journal of Dental Hygiene, Vol. 81, Iss. 5, 2007-12 ,pp. : 117-117

American Dental Hygienists' Association

Access to resources Recommend Favorite